CENTURY ALUMINUM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Century Aluminum Co.
The law firm of Kahn Swick & Foti, LLC ('KSF') has commenced an investigation into Century Aluminum Company (NasdaqGS: CENX) ('Century'). KSF is investigating whether Century's officers and/or directors breached their fiduciary duties or otherwise violated state or federal laws.
If you hold shares of Century Aluminum Company (NasdaqGS: CENX), we urge you to contact KSF to discuss your legal rights, without obligation or cost to you, by calling KSF toll-free at 1-833-938-0905, or by e-mailing KSF Managing Partner, Lewis Kahn, ( [email protected] ), or visit https://www.ksfcounsel.com/cases/nasdaqgs-cenx/ to learn more.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, New Jersey, and a representative office in Luxembourg.
TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services
To learn more about KSF, you may visit www.ksfcounsel.com.
CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn
View source version on businesswire.com:https://www.businesswire.com/news/home/20250718817125/en/
CONTACT: Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163
KEYWORD: UNITED STATES NORTH AMERICA LOUISIANA NEW YORK
INDUSTRY KEYWORD: CLASS ACTION LAWSUIT PROFESSIONAL SERVICES LEGAL
SOURCE: Kahn Swick & Foti, LLC
Copyright Business Wire 2025.
PUB: 07/18/2025 07:28 PM/DISC: 07/18/2025 07:28 PM
http://www.businesswire.com/news/home/20250718817125/en
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 minutes ago
- Yahoo
Thermo Fisher beats quarterly estimates on resilient demand for its tools and services
(Reuters) -Thermo Fisher on Wednesday beat Wall Street estimates for second-quarter profit and revenue, helped by steady demand for its products and services used for developing therapies. Shares of the medical equipment maker were up 2.5% in premarket trading. The company joins peers such as Danaher in beating quarterly profit estimates, citing strong demand from the industry for tools and services used to make vaccines and therapies. Danaher said on Tuesday it is seeing a robust number of clinical trials and therapies under development, with steady demand from its pharmaceutical clients. On an adjusted basis, Thermo Fisher reported a profit of $5.36 per share for the quarter ended June 28, beating analysts' estimate of $5.22 per share, as per data compiled by LSEG. The company said its business strategy called "practical process improvement" is helping adjust its supply chains in the tariff environment and to actively manage its cost base. Last week, the company said it will buy French drugmaker Sanofi's New Jersey manufacturing site, "to meet growing demand from pharma and biotech customers." The Waltham Massachusetts-based company's quarterly revenue rose 3% to $10.85 billion, compared to analyst estimates of $10.68 billion. Sales at its laboratory products segment, which makes up more than half of Thermo Fisher's total sales came in at $6 billion, above estimates of $5.79 billion. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
9 minutes ago
- Yahoo
Highly shorted Krispy Kreme, GoPro jump as meme stock rally continues
(Reuters) -Shares of some highly-shorted companies, including Krispy Kreme and GoPro, jumped in premarket trading on Wednesday, aided by their names trending on social media forums a day after retail traders piled into department store company Kohl's. Doughnut chain Krispy Kreme jumped 16.1%, building on a near 27% surge on Tuesday. About 14% of Krispy Kreme's outstanding shares available for trading are shorted, according to data compiled by LSEG. Camera maker GoPro also surged about 47% to $2.01. Short interest on the stock was last at 7.7%. Another highly shorted stock - with short interest at 36.7% - was plant-based meat company Beyond Meat, whose shares jumped 10.4% on Wednesday. The growing interest in heavily shorted stocks comes after Kohl's surged 37.6% higher in volatile trading on Tuesday on the back of high retail interest. Mom-and-pop traders bought $9.64 million of its shares that day, the most by this category of investors in about three years, according to data from Vanda Research. Kohl's was flat in premarket trading on Wednesday but is the third most trending ticker on Stocktwits, a retail investor-focused social media platform. Among other highly shorted names, online gifts retailer rose 8.1%. Opendoor Technologies, which has rocketed 440% so far this month, was down 2.6% on Wednesday.
Yahoo
9 minutes ago
- Yahoo
Thermo Fisher shares climb as Q2 top and bottom line exceed estimates
-- Thermo Fisher Scientific Inc (NYSE:TMO) reported second-quarter earnings that topped expectations, with revenue also coming in ahead of forecasts. The company reported adjusted EPS of $5.36, beating the analyst estimate of $5.23. Revenue rose 3% from a year earlier to $10.85 billion, above the $10.68 billion consensus. Shares in the medical equipment maker were up 2.3% in premarket trading Wednesday as of 06:06 ET. 'Our exceptional team continues to execute at a high level, enabling customer success while navigating the macroenvironment," said Marc N. Casper, chairman, president, and CEO of Thermo Fisher Scientific. Adjusted operating income reached $2.38 billion, slightly up from $2.35 billion in the same period last year. Adjusted operating margin slipped to 21.9% from 22.3% a year ago. Related articles Thermo Fisher shares climb as Q2 top and bottom line exceed estimates These Under-the-Radar Stocks Offer Better Risk-Reward Ratio Than Nvidia If Powell goes, does Fed trust go with him?
